Peter Kolchinsky’s RA Capital Buys More Tengion $TNGN

Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.

Peter Kolchinsky

RA Capital disclosed a 5.4% stake in Tengion Inc (TNGN) last week. Kolchinsky now owns 1,275,620 shares of TNGN. He initiated a brand new 1,060,070 share position in TNGN during the first quarter. It seems like he increased his bet by 20% as the stock price plunged from $2.55 at the end of March to $1.41 today. Tengion is a micro-cap stock with a market value of $33 Million. Its daily volume is a little more than $200,000. Brookside Capital had a $1.8 Million position in TNGN at the end of March as well.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!